| pubmed-article:21493743 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21493743 | lifeskim:mentions | umls-concept:C0231335 | lld:lifeskim |
| pubmed-article:21493743 | lifeskim:mentions | umls-concept:C0017661 | lld:lifeskim |
| pubmed-article:21493743 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:21493743 | lifeskim:mentions | umls-concept:C0282440 | lld:lifeskim |
| pubmed-article:21493743 | lifeskim:mentions | umls-concept:C1096777 | lld:lifeskim |
| pubmed-article:21493743 | lifeskim:mentions | umls-concept:C0443252 | lld:lifeskim |
| pubmed-article:21493743 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:21493743 | pubmed:dateCreated | 2011-6-9 | lld:pubmed |
| pubmed-article:21493743 | pubmed:abstractText | Children with IgA nephropathy showing diffuse (>80%) mesangial proliferation are at high risk for end-stage renal failure (ESRF). A previous controlled trial showed that combination therapy consisting of prednisolone, azathioprine, heparin-warfarin, and dipyridamole early in the course of disease reduces immunologic renal injury and prevents the progression of sclerosed glomeruli. The objective of this study was to evaluate the long-term effectiveness of combination therapy in children with IgA nephropathy showing diffuse mesangial proliferation. | lld:pubmed |
| pubmed-article:21493743 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21493743 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21493743 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21493743 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21493743 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21493743 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21493743 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21493743 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21493743 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21493743 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21493743 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21493743 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:21493743 | pubmed:issn | 1555-905X | lld:pubmed |
| pubmed-article:21493743 | pubmed:author | pubmed-author:IshikuraKenji... | lld:pubmed |
| pubmed-article:21493743 | pubmed:author | pubmed-author:HatayaHiroshi... | lld:pubmed |
| pubmed-article:21493743 | pubmed:author | pubmed-author:HondaMasataka... | lld:pubmed |
| pubmed-article:21493743 | pubmed:author | pubmed-author:SaitoMariM | lld:pubmed |
| pubmed-article:21493743 | pubmed:author | pubmed-author:NakanishiKoic... | lld:pubmed |
| pubmed-article:21493743 | pubmed:author | pubmed-author:YoshikawaNori... | lld:pubmed |
| pubmed-article:21493743 | pubmed:author | pubmed-author:IijimaKazumot... | lld:pubmed |
| pubmed-article:21493743 | pubmed:author | pubmed-author:ItoShuichiS | lld:pubmed |
| pubmed-article:21493743 | pubmed:author | pubmed-author:SakoMayumiM | lld:pubmed |
| pubmed-article:21493743 | pubmed:author | pubmed-author:KameiKoichiK | lld:pubmed |
| pubmed-article:21493743 | pubmed:author | pubmed-author:Japanese... | lld:pubmed |
| pubmed-article:21493743 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21493743 | pubmed:volume | 6 | lld:pubmed |
| pubmed-article:21493743 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21493743 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21493743 | pubmed:pagination | 1301-7 | lld:pubmed |
| pubmed-article:21493743 | pubmed:meshHeading | pubmed-meshheading:21493743... | lld:pubmed |
| pubmed-article:21493743 | pubmed:meshHeading | pubmed-meshheading:21493743... | lld:pubmed |
| pubmed-article:21493743 | pubmed:meshHeading | pubmed-meshheading:21493743... | lld:pubmed |
| pubmed-article:21493743 | pubmed:meshHeading | pubmed-meshheading:21493743... | lld:pubmed |
| pubmed-article:21493743 | pubmed:meshHeading | pubmed-meshheading:21493743... | lld:pubmed |
| pubmed-article:21493743 | pubmed:meshHeading | pubmed-meshheading:21493743... | lld:pubmed |
| pubmed-article:21493743 | pubmed:meshHeading | pubmed-meshheading:21493743... | lld:pubmed |
| pubmed-article:21493743 | pubmed:meshHeading | pubmed-meshheading:21493743... | lld:pubmed |
| pubmed-article:21493743 | pubmed:meshHeading | pubmed-meshheading:21493743... | lld:pubmed |
| pubmed-article:21493743 | pubmed:meshHeading | pubmed-meshheading:21493743... | lld:pubmed |
| pubmed-article:21493743 | pubmed:meshHeading | pubmed-meshheading:21493743... | lld:pubmed |
| pubmed-article:21493743 | pubmed:meshHeading | pubmed-meshheading:21493743... | lld:pubmed |
| pubmed-article:21493743 | pubmed:meshHeading | pubmed-meshheading:21493743... | lld:pubmed |
| pubmed-article:21493743 | pubmed:meshHeading | pubmed-meshheading:21493743... | lld:pubmed |
| pubmed-article:21493743 | pubmed:meshHeading | pubmed-meshheading:21493743... | lld:pubmed |
| pubmed-article:21493743 | pubmed:meshHeading | pubmed-meshheading:21493743... | lld:pubmed |
| pubmed-article:21493743 | pubmed:meshHeading | pubmed-meshheading:21493743... | lld:pubmed |
| pubmed-article:21493743 | pubmed:meshHeading | pubmed-meshheading:21493743... | lld:pubmed |
| pubmed-article:21493743 | pubmed:meshHeading | pubmed-meshheading:21493743... | lld:pubmed |
| pubmed-article:21493743 | pubmed:meshHeading | pubmed-meshheading:21493743... | lld:pubmed |
| pubmed-article:21493743 | pubmed:meshHeading | pubmed-meshheading:21493743... | lld:pubmed |
| pubmed-article:21493743 | pubmed:meshHeading | pubmed-meshheading:21493743... | lld:pubmed |
| pubmed-article:21493743 | pubmed:meshHeading | pubmed-meshheading:21493743... | lld:pubmed |
| pubmed-article:21493743 | pubmed:meshHeading | pubmed-meshheading:21493743... | lld:pubmed |
| pubmed-article:21493743 | pubmed:meshHeading | pubmed-meshheading:21493743... | lld:pubmed |
| pubmed-article:21493743 | pubmed:meshHeading | pubmed-meshheading:21493743... | lld:pubmed |
| pubmed-article:21493743 | pubmed:meshHeading | pubmed-meshheading:21493743... | lld:pubmed |
| pubmed-article:21493743 | pubmed:meshHeading | pubmed-meshheading:21493743... | lld:pubmed |
| pubmed-article:21493743 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21493743 | pubmed:articleTitle | Long-term results of a randomized controlled trial in childhood IgA nephropathy. | lld:pubmed |
| pubmed-article:21493743 | pubmed:affiliation | Department of Nephrology, National Center for Child Health and Development, Setagaya, Tokyo, Japan. | lld:pubmed |
| pubmed-article:21493743 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21493743 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:21493743 | pubmed:publicationType | Meta-Analysis | lld:pubmed |
